Cargando…

Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes

Increased autoantibody reactivity in plasma from Myelodysplastic Syndromes (MDS) patients may provide novel disease signatures, and possible early detection. In a two-stage study we investigated Immunoglobulin G reactivity in plasma from MDS, Acute Myeloid Leukemia post MDS patients, and a healthy c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mias, George I., Chen, Rui, Zhang, Yan, Sridhar, Kunju, Sharon, Donald, Xiao, Li, Im, Hogune, Snyder, Michael P., Greenberg, Peter L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837310/ https://www.ncbi.nlm.nih.gov/pubmed/24264604 http://dx.doi.org/10.1038/srep03311

Ejemplares similares

Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation
por: Behbehani, Gregory K., et al.
Publicado: (2020)

Myelodysplastic syndromes: moving towards personalized management
por: Hellström-Lindberg, Eva, et al.
Publicado: (2020)

Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome
por: Singhal, Deepak, et al.
Publicado: (2017)

Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups
por: Majek, Pavel, et al.
Publicado: (2015)

Metchnikoff’s legacy: the dysplastic nature of innate immunity in myelodysplastic syndromes
por: Greenberg, Peter L.
Publicado: (2021)

Nuclear Nox4-Derived Reactive Oxygen Species in Myelodysplastic Syndromes
por: Guida, Marianna, et al.
Publicado: (2014)

Gut Microbiome and Plasma Metabolomic Analysis in Patients with Myelodysplastic Syndrome
por: Jiang, Huijuan, et al.
Publicado: (2022)

Gingival enlargement in myelodysplastic syndrome
por: George, Navia, et al.
Publicado: (2015)

Myelodysplastic syndromes
por: Hellström Lindberg, Eva
Publicado: (2018)

Autoantibodies in Senear-Usher Syndrome: Cross-Reactivity or Multiple Autoimmunity?
por: Pérez-Pérez, María Elena, et al.
Publicado: (2012)

Telomere integrated scoring system of myelodysplastic syndrome
por: Park, Hee Sue, et al.
Publicado: (2023)

Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome
por: Pecankova, Klara, et al.
Publicado: (2022)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

Myelodysplastic syndromes and overlap syndromes
por: Chang, Yoon Hwan
Publicado: (2021)

Angiogenesis in myelodysplastic syndromes
por: Pruneri, G, et al.
Publicado: (1999)

Myelodysplastic Syndromes and Metabolism
por: Balaian, Ekaterina, et al.
Publicado: (2021)

Genetics of Myelodysplastic Syndromes
por: Saygin, Caner, et al.
Publicado: (2021)

Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome
por: Huang, Christina, et al.
Publicado: (2023)

Personal genomes, quantitative dynamic omics and personalized medicine
por: Mias, George I., et al.
Publicado: (2013)

Myelodysplastic Syndrome and Autoimmunity: A Case Report of an Unusual Presentation of Myelodysplastic Syndrome
por: Merrill, Andrea L., et al.
Publicado: (2011)

Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome
por: Park, Hee Sue, et al.
Publicado: (2017)

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
por: Huang, Huijun, et al.
Publicado: (2021)

Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome
por: Hrustincova, Andrea, et al.
Publicado: (2020)

Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
por: Komrokji, Rami S., et al.
Publicado: (2022)

Elevated Plasma P-Selectin Autoantibodies in Primary Sjögren Syndrome Patients with Thrombocytopenia
por: Hu, Ya-Hui, et al.
Publicado: (2015)

Cervical carcinoma following myelodysplastic syndrome: A case report
por: MENG, DU, et al.
Publicado: (2014)

Decitabine in the treatment of myelodysplastic syndromes
por: Saba, Hussain I
Publicado: (2007)

Cytogenetic features in myelodysplastic syndromes
por: Haase, Detlef
Publicado: (2008)

New Treatments for Myelodysplastic Syndromes
por: D’Alò, Francesco, et al.
Publicado: (2010)

Immune dysregulation in myelodysplastic syndrome
por: Sugimori, Chiharu, et al.
Publicado: (2010)

Comet assay in myelodysplastic syndromes
por: Teixeira Neto, Paulo Florentino, et al.
Publicado: (2012)

Incidence of Myelodysplastic Syndrome in Japan
Publicado: (2014)

Molecular Pathogenesis of Myelodysplastic Syndromes
por: Visconte, Valeria, et al.
Publicado: (2014)

Incidence and Burden of the Myelodysplastic Syndromes
por: Cogle, Christopher R.
Publicado: (2015)

Immune Mechanisms in Myelodysplastic Syndrome
por: Glenthøj, Andreas, et al.
Publicado: (2016)

Hereditary Predispositions to Myelodysplastic Syndrome
por: Bannon, Sarah A., et al.
Publicado: (2016)

Preclinical modeling of myelodysplastic syndromes
por: Rouault-Pierre, K, et al.
Publicado: (2017)

Myelodysplastic Syndrome in Hemodialysis Patients
por: Ayari, Hamza, et al.
Publicado: (2019)

Clonal evolution in myelodysplastic syndromes
por: da Silva-Coelho, Pedro, et al.
Publicado: (2017)

Diagnostics and Prognostication of Myelodysplastic Syndromes
por: Zini, Gina
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h5sh2jht4pa8860ucij46snru5